Plant Comparison
Purple coneflower vs Shiitake (mushroom)
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Purple coneflower and Shiitake (mushroom): they share 4 indicated uses (cold & flu, immune support, infection (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Purple coneflower | Shiitake (mushroom) | Verdict |
|---|---|---|---|
| Cold & flu | 1/10 | 5/10 | Stronger for Shiitake (mushroom) |
| Immune support | 1/10 | 5/10 | Stronger for Shiitake (mushroom) |
| Infection (general) | 1/10 | 5/10 | Stronger for Shiitake (mushroom) |
| Wounds | 1/10 | 5/10 | Stronger for Shiitake (mushroom) |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Lipophilic alkamides are considered key immunomodulatory and anti-inflammatory constituents, particularly concentrated in the root.
Antioxidant phenolic compounds contributing to the plant's immunomodulatory activity.
Water-soluble polysaccharides associated with immune-stimulating activity, particularly from the aerial parts.
The principal immunomodulatory polysaccharide, used clinically in Japan as an injectable cancer-adjuvant therapy.
A unique amino-acid-derived compound studied for cholesterol-lowering activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from antimicrobial action
inferred from antidiabetic action
Safety, Cautions & Contraindications
Generally considered safe, but caution advised for those with autoimmune conditions. Not recommended for long-term use (more than 8 weeks continuously).
Duke (2002) rates echinacea as +++ — among the most thoroughly documented herbal immunostimulants. It notes experimental and clinical evidence for immunostimulant, antiviral, and anti-inflammatory activities. Multiple species have been studied (E. purpurea, E. angustifolia, E. pallida), and Duke emphasizes that species identification in commercial products is often unreliable. Commission E approves E. purpurea for supporting immune function during colds and flu. Dose: 900 mg standardized extract daily in acute use; use should be limited to 8 weeks continuous. Contraindicated in autoimmune diseases (MS, lupus, HIV/AIDS), tuberculosis, and with immunosuppressive drugs (cyclosporine) (Duke, 2002).
Generally very safe as a food. Raw or undercooked shiitake can cause a rare skin rash (shiitake dermatitis / flagellate dermatitis) in sensitive individuals — fully cooking eliminates this risk. May have mild anticoagulant effects. Rarely causes digestive upset. Well tolerated in normal culinary quantities.
Duke (2002) rates shiitake as +++ and notes immunostimulant, hypocholesterolemic, antibacterial, and anti-HIV activities at the experimental level (score 1). The key active compound is lentinan, a beta-1,3-glucan polysaccharide, which is used as an injectable anticancer drug in Japan. Duke notes clinical applications of shiitake preparations for immune support, cancer adjuvant therapy, and cholesterol management. Dose: 1–3 (606 mg) capsules up to three times daily for standardized preparations. Shiitake dermatitis (flagellate erythema) is a rare but recognized adverse effect from eating raw or undercooked shiitake — cooking prevents this (Duke, 2002).
External Ids
Botanical Description
Robust perennial herb with a basal rosette of coarse, hairy, lance-shaped leaves and tall, sturdy flowering stems. Each stem bears a single large, daisy-like flower head with drooping (reflexed), rose-purple to pink ray florets surrounding a prominent, spiny, orange-brown central cone of disc florets.[4]
Wood-decay fungus (not a true plant) with a classic cap-and-stem mushroom form. The cap is broad, brown to dark brown, often with pale scale-like markings, with a fringed or curled margin when young; the underside bears numerous cream-coloured gills radiating from a central or slightly off-centre fibrous stem.
Habitat
Native to the tallgrass prairies, open woodland and dry meadows of central and eastern North America; widely cultivated worldwide as a garden and medicinal plant.[4]
Grows naturally as a wood-decay fungus on fallen broadleaf trees (notably shii, oak and chestnut) in East Asian forests; almost all commercial shiitake today is cultivated on hardwood logs or sawdust blocks.
Harvesting
The flower heads are picked as they open, in summer; the root is dug in autumn from plants at least two to three years old, when its content of bioactive alkamides and caffeic acid derivatives is highest, then cleaned and dried.[4]
Fruiting bodies are hand-picked once the cap has opened but before the margin fully flattens, then used fresh or dried; mycelium-based extracts are cultivated separately in liquid or grain culture.
Traditional Uses
Echinacea root was widely used by Native American peoples as a remedy for infections, wounds, snakebite and toothache, and entered nineteenth-century Eclectic medicine as a broad anti-infective. It remains best known today, in standardised aerial-part or root extracts, as a supportive remedy for preventing and shortening the common cold and supporting immune function.[1, 4]
Shiitake has a very long East Asian culinary and medicinal tradition, used in Chinese and Japanese medicine as a tonic for vitality and longevity and to support healthy qi and blood; its polysaccharide lentinan, isolated from the fruiting body, has been used clinically in Japan as an adjunct immunotherapy, directly building on this traditional immune-tonic reputation.[11]
Preparations
Fresh-pressed juice or standardised extract of the aerial parts or root, taken as tablets, drops or capsules at the first sign of a cold; the best-studied clinical form.
Fruiting-body or mycelium extract standardised to polysaccharide (lentinan/beta-glucan) content, taken as capsules for immune support.
Dosage
Clinical trials for the common cold commonly use around 300-900 mg of standardised extract daily, started at the first sign of symptoms and continued for up to 7-10 days; continuous use beyond about 8 weeks is not recommended. Educational reference only, not a prescription.
Not documented
References
Drug Class Interactions
Not documented
Lookalikes Review
References & Sources
- Karsch-Völk, M., Barrett, B., Kiefer, D., Bauer, R. et al (2014) 'Echinacea for preventing and treating the common cold', Cochrane Database of Systematic Reviews, 2(2), pp. CD000530. doi:10.1002/14651858.CD000530.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD000530.pub3 - Kamin, W., Seifert, G., Zwiauer, K., Bonhoeffer, J. et al (2025) 'Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review', Frontiers in Pediatrics, 13, pp. 1423250. doi:10.3389/fped.2025.1423250 Meta-analysis / review
https://doi.org/10.3389/fped.2025.1423250 - Fashner, J., Ericson, K. and Werner, S (2012) 'Treatment of the common cold in children and adults', American Family Physician, 86(2), pp. 153-159. Available at: https://pubmed.ncbi.nlm.nih.gov/22962927/ Traditional / reference
https://pubmed.ncbi.nlm.nih.gov/22962927/ - Manayi, A., Vazirian, M. and Saeidnia, S (2015) 'Echinacea purpurea: Pharmacology, phytochemistry and analysis methods', Pharmacognosy Reviews, 9(17), pp. 63-72. doi:10.4103/0973-7847.156353 Meta-analysis / review
https://doi.org/10.4103/0973-7847.156353 - Burlou-Nagy, C., Banica, F., Jurca, T., Vicas, L.G., Marian, E., Muresan, M.E., Bacskay, I., Kiss, R., Feher, P. and Pallag, A (2022) 'Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review', Plants, 11(9), pp. 1244. doi:10.3390/plants11091244 Meta-analysis / review
https://doi.org/10.3390/plants11091244 - Hall, H., Fahlman, M.M. and Engels, H.J (2007) 'Echinacea purpurea and mucosal immunity', International Journal of Sports Medicine, 28(9), pp. 792-797. doi:10.1055/s-2007-964895 Randomized trial
https://doi.org/10.1055/s-2007-964895 - Ross, S.M (2016) 'Echinacea purpurea: A Proprietary Extract of Echinacea purpurea Is Shown to be Safe and Effective in the Prevention of the Common Cold', Holistic Nursing Practice, 30(1), pp. 54-57. doi:10.1097/HNP.0000000000000130 Meta-analysis / review
https://doi.org/10.1097/HNP.0000000000000130 - Hudson, J.B (2011) 'Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases', Journal of Biomedicine & Biotechnology, 2012, pp. 769896. doi:10.1155/2012/769896 Meta-analysis / review
https://doi.org/10.1155/2012/769896 - Mishima, S., Saito, K., Maruyama, H., Inoue, M., Yamashita, T., Ishida, T. and Gu, Y (2004) 'Antioxidant and immuno-enhancing effects of Echinacea purpurea', Biological & Pharmaceutical Bulletin, 27(7), pp. 1004-1009. doi:10.1248/bpb.27.1004 Preclinical
https://doi.org/10.1248/bpb.27.1004 - Saunders, P.R., Smith, F. and Schusky, R.W (2007) 'Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections', Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1195-1199. doi:10.1139/Y07-103 Clinical study
https://doi.org/10.1139/Y07-103 - Micheli, L., Maggini, V., Ciampi, C., Gallo, E., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Di Cesare Mannelli, L., De Leo, M. and Firenzuoli, F (2022) 'Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy', Phytotherapy Research, 37(5), pp. 1911-1923. doi:10.1002/ptr.7709 Preclinical
https://doi.org/10.1002/ptr.7709 - Gholami, M., Amri, J., Pazhoohan, S. and Sadegh, M (2021) 'Anticonvulsive and anti-epileptogenesis effects of Echinacea purpurea root extract, an involvement of CB2 receptor', Journal of Complementary & Integrative Medicine, 19(4), pp. 879-886. doi:10.1515/jcim-2020-0219 Preclinical
https://doi.org/10.1515/jcim-2020-0219 - Awortwe, C., Bruckmueller, H., Kaehler, M. and Cascorbi, I (2021) 'Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters', Molecular Pharmaceutics, 18(4), pp. 1622-1633. doi:10.1021/acs.molpharmaceut.0c01075 Preclinical
https://doi.org/10.1021/acs.molpharmaceut.0c01075 - Perry, N.B., van Klink, J.W., Burgess, E.J. and Parmenter, G.A (1997) 'Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers', Planta Medica, 63(1), pp. 58-62. doi:10.1055/s-2006-957605 Preclinical
https://doi.org/10.1055/s-2006-957605 - Linde, K., Barrett, B., Wölkart, K., Bauer, R. and Melchart, D (2006) 'Echinacea for preventing and treating the common cold'. Traditional / reference
https://scholar.google.com/scholar?q=Echinacea%20for%20preventing%20and%20treating%20the%20common%20cold - Sharma, M., Schoop, R., Suter, A. and Schoop, W (2010) 'The possibility of prophylactic treatment of streptococcal pharyngotonsillitis with a standardized Echinacea preparation', 29(8), pp. 1025--1035. Traditional / reference
https://scholar.google.com/scholar?q=The%20possibility%20of%20prophylactic%20treatment%20of%20streptococcal%20pharyngotonsillitis%20with%20a%20standardized%20Echinacea%20preparation - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Gorski, J.C., Huang, S.M., Pinto, A., Hamman, M.A., Hilligoss, J.K., Zaheer, N.A., Desai, M., Miller, M. and Hall, S.D (2004) 'The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo', Clinical Pharmacology and Therapeutics, 75(1), pp. 89-100. doi:10.1016/j.clpt.2003.09.013 Clinical study
https://doi.org/10.1016/j.clpt.2003.09.013
- Jafari, M., Boskabady, M.H., Rezaee, S.A., Rezaeian, S. and others (2023) 'Lentinan and beta-glucan extract from shiitake mushroom, Lentinula edodes, alleviate acute LPS-induced hematological changes in mice', Iranian Journal of Basic Medical Sciences, 26(7), pp. 836-842. doi:10.22038/IJBMS.2023.67669.14820 Preclinical
https://doi.org/10.22038/IJBMS.2023.67669.14820 - Ahn, H., Jeon, E., Kim, J.C., Kang, S.G. and others (2017) 'Lentinan from shiitake selectively attenuates AIM2 and non-canonical inflammasome activation while inducing pro-inflammatory cytokine production', Scientific Reports, 7(1), pp. 1314. doi:10.1038/s41598-017-01462-4 Preclinical
https://doi.org/10.1038/s41598-017-01462-4 - Okamoto, T., Kodoi, R., Nonaka, Y., Fukuda, I. and others (2004) 'Lentinan from shiitake mushroom (Lentinus edodes) suppresses expression of cytochrome P450 1A subfamily in the mouse liver', BioFactors, 21(1-4), pp. 407-409. doi:10.1002/biof.552210180 Preclinical
https://doi.org/10.1002/biof.552210180 - Ng, M.L. and Yap, A.T (2002) 'Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes)', Journal of Alternative and Complementary Medicine, 8(5), pp. 581-589. doi:10.1089/107555302320825093 Preclinical
https://doi.org/10.1089/107555302320825093 - Bisen, P.S., Baghel, R.K., Sanodiya, B.S., Thakur, G.S. and Prasad, G.B.K.S (2010) 'Lentinus edodes: a macrofungus with pharmacological activities', Current Medicinal Chemistry, 17(22), pp. 2419-2430. doi:10.2174/092986710791698495 Meta-analysis / review
https://doi.org/10.2174/092986710791698495 - Stephany, M.P., Chung, S., Handler, M.Z., Handler, N.S. and others (2016) 'Shiitake Mushroom Dermatitis: A Review', American Journal of Clinical Dermatology, 17(5), pp. 485-489. doi:10.1007/s40257-016-0212-6 Meta-analysis / review
https://doi.org/10.1007/s40257-016-0212-6 - Nguyen, A.H., Gonzaga, M.I., Lim, V.M., Adler, M.J. and others (2017) 'Clinical features of shiitake dermatitis: a systematic review', International Journal of Dermatology, 56(6), pp. 610-616. doi:10.1111/ijd.13433 Meta-analysis / review
https://doi.org/10.1111/ijd.13433 - Djordjevic, B., Skugor, S., Jorgensen, S.M., Overland, M. and others (2009) 'Modulation of splenic immune responses to bacterial lipopolysaccharide in rainbow trout (Oncorhynchus mykiss) fed lentinan, a beta-glucan from mushroom Lentinula edodes', Fish & Shellfish Immunology, 26(2), pp. 201-209. doi:10.1016/j.fsi.2008.10.012 Preclinical
https://doi.org/10.1016/j.fsi.2008.10.012 - Kaleta, B., Gorski, A., Zagozdzon, R., Cieslak, M. and others (2019) 'Selenium-containing polysaccharides from Lentinula edodes-Biological activity', Carbohydrate Polymers, 223, pp. 115078. doi:10.1016/j.carbpol.2019.115078 Preclinical
https://doi.org/10.1016/j.carbpol.2019.115078 - Money, N.P (2016) 'Are mushrooms medicinal?', Fungal Biology, 120(4), pp. 449-453. doi:10.1016/j.funbio.2016.01.006 Meta-analysis / review
https://doi.org/10.1016/j.funbio.2016.01.006 - Vethanayagam, R.R. et al (1996) 'Lentinan — a novel immunomodulator', 54(2), pp. 25--30. Traditional / reference
https://scholar.google.com/scholar?q=Lentinan%20%E2%80%94%20a%20novel%20immunomodulator - Wasser, S.P (2011) 'Current findings, future trends, and unsolved problems in studies of medicinal mushrooms', 89(5), pp. 1323--1332. doi:10.1007/s00253-010-3067-4 Randomized trial
https://doi.org/10.1007/s00253-010-3067-4 - Yokota, M (1989) 'Observatory trial of anti-obesity activity of Eritadenine', pp. 1--4. Traditional / reference
https://scholar.google.com/scholar?q=Observatory%20trial%20of%20anti-obesity%20activity%20of%20Eritadenine - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.